AN2 Therapeutics Inc.

ANTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.53

-$0.16 (-3.41%)

At close: Oct 30, 2026, 4:00 PM ET

$4.53

$0.00 (0.00%)

Pre-market: Nov 2, 2026, 5:27 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Cash & Equivalents	19.94M	21.35M	15.65M	27.22M	12.1M	4.07M
Short-Term Investments	38.06M	62.27M	91.65M	68.84M	46.46M	n/a
Long-Term Investments	2.01M	5.02M	27.19M	3.22M	3.49M	n/a
Other Long-Term Assets	n/a	804K	1.04M	667K	1.72M	n/a
Receivables	900K	300K	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.04M	2.34M	3.21M	2.56M	n/a	0
Total Current Assets	59.94M	86.26M	110.51M	98.62M	60.11M	4.23M
Property-Plant & Equipment	n/a	n/a	n/a	53K	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	2.01M	5.83M	28.24M	3.94M	5.21M	n/a
Total Assets	61.95M	92.09M	138.74M	102.56M	65.32M	4.23M
Account Payables	3.02M	3.32M	2.68M	2.12M	1.06M	132K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	3.28M	2.47M	4.69M	6K	933K	14K
Total Current Liabilities	8.72M	10.24M	14.04M	7.19M	3.4M	1.46M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	170K	n/a	n/a	2K	13K	24K
Total Long-Term Liabilities	170K	n/a	n/a	2K	13K	24K
Total Liabilities	8.89M	10.24M	14.04M	7.19M	3.41M	1.48M
Total Debt	n/a	n/a	n/a	53K	n/a	n/a
Book Value	53.06M	81.85M	124.7M	95.37M	61.91M	2.75M
Book Value Per Share	1.76	2.74	5.28	6.22	3.30	0.15
Common Stock	n/a	n/a	n/a	n/a	n/a	n/a
Retained Earnings	-240.95M	-205.78M	-154.46M	-89.72M	-47.38M	-20.32M
Comprehensive Income	57K	31K	275K	-374K	-27K	n/a
Shareholders Equity	53.06M	81.85M	124.7M	95.37M	61.91M	2.75M
Total Investments	40.07M	67.29M	118.84M	72.06M	49.94M	n/a